2010 Cannabis Clinical Trials Pharmaceutical 
Cannabis Law Report
DECEMBER 9, 2021
08, 2021 (GLOBE NEWSWIRE) — Algernon Pharmaceuticals Inc. The Company believes it has produced a sufficient supply of cGMP DMT to complete its planned Phase 1 and Phase 2 clinical trials. as medical consultants to the Company’s DMT stroke clinical research program. Moreau CEO of Algernon Pharmaceuticals Inc. “We
Cannabis Law Report
JANUARY 4, 2022
AUSTIN, Texas–(BUSINESS WIRE)–Anebulo Pharmaceuticals, Inc. NYSE: AMAM), a position he previously held from 2010 through 2015. About Anebulo Pharmaceuticals, Inc. Anebulo Pharmaceuticals, Inc. Allen succeeds Daniel Schneeberger, MD, who has resigned as CEO and as a Director as of that same date. and Australia.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
SpeedWeed
MARCH 18, 2021
Preliminary results from a long-awaited study indicate that cannabis appears to be a safe and well-tolerated treatment for patients managing post-traumatic stress disorder (PTSD), although researchers did not find strong signals of effectiveness. One group self-administered cannabis with 12% THC over three weeks.
Cannabis Law Report
JULY 6, 2021
He was also listed in “Best Doctors in America” in 2007, 2009, and 2010. Dr. Bankole Johnson was also the founder of NASDAQ listed Adial Pharmaceuticals (NASDAQ: ADIL) and currently serves as its Chief Medical Officer. Johnson received the R. Brinkley Smithers award from the American Association of Addiction Medicine.
CannaMD
AUGUST 8, 2020
– because today’s post is a deep dive into everything you need to know about the most popular cannabis compound around. Let’s clear up one of the biggest sources of confusion right off the bat: CBD is a cannabis compound called cannabidiol. Researchers believe cannabis contains over 100 unique chemical compounds!
Cannabis Law Report
JULY 28, 2021
Cepharanthine is on its way to establishing itself as a once per day, oral anti-cancer therapeutic with a well-established safety profile which will pave the way for an expedited clinical development pathway and future partnering opportunities with pharmaceutical companies. ” Next Steps. Cepharanthine’s Rationale in Cancer.
SMPL
MAY 26, 2020
A headstrong biochemist, she had been growing marijuana since the age of 14 and had just quit a six-figure job to start her own cannabis testing lab. Cannabis containing significant amounts of CBD was still rare. Cannabis that is high in CBD but extremely low in THC was made legal at the end of 2018.
Expert insights. Personalized for you.
52 
Let's personalize your content